Erin Brazel, PhD

Erin is Director of Microbiology at GPN Vaccines and a Research Fellow at the University of Adelaide. With over ten years’ experience in pneumococcal biology and translational innovation in vaccines and therapeutics, she has helped advance GPN’s pneumococcal vaccine program and led the expansion of the company’s bacterial vaccine pipeline from discovery through preclinical evaluation. She completed her PhD in pneumococcal biology and therapeutic development at the University of Adelaide in 2020. In 2023, she established the Molecular & Translational Microbiology Group, where she supervises GPN-supported graduate students and leads research into pathogenesis, vaccine design and translational strategy. Erin has secured more than $1 million in research, fellowship and student support funding, is a co-inventor on three patents in Streptococcal vaccine design, and in 2024 received the prestigious Passe & Williams Foundation Fellowship.